))
The Dark Side of Med Device Kickbacks
Manage episode 440443012 series 3506216
Contenido proporcionado por Darshan Kulkarni. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Darshan Kulkarni o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Today, we're discussing a critical issue for pharmaceutical and medical device marketers – promotional compliance.
Overview of the Innovasis Settlement:
Innovasis Inc. recently settled a $12 million case for alleged kickback schemes to doctors. This highlights the importance of promotional compliance.
Allegations Against Innovasis:
From Jan. 1, 2014, to Dec. 31, 2022, Innovasis allegedly provided improper remuneration to surgeons, inducing them to use their products. These remunerations included consulting fees, IP acquisition fees, travel, and lavish events.
Implications for Compliance Practices:
Regulatory bodies like the FDA and DOJ are closely monitoring promotional practices. Companies must ensure both effectiveness and compliance in their marketing strategies.
Key Strategies for Compliance:
Transparency and documentation are vital in all interactions with healthcare professionals. Training and education are essential to understand boundaries, and internal audits help identify and rectify compliance issues early.
Conclusion:
Compliance safeguards reputation and builds trust. For assistance with compliance strategy, contact the Kulkarni Law Firm.
138 episodios
Compartir
